Financial Statements — CTOR
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 |
|---|
| Cash & Equivalents | 2.63 | 7.30 | 0.00 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Accounts Receivable | 1.08 | 4.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Inventory | 22.66 | 22.64 | 17.21 | 15.34 | 14.38 | -- | -- | -- | -- | -- | -- |
| Total Current Assets | 29.42 | 37.15 | 18.31 | 18.04 | 17.08 | 0.04 | 0.09 | 0.09 | 0.46 | 0.25 | -- |
| Total Non-current Assets* | 71.28 | 72.83 | 73.40 | 73.40 | 73.40 | 49.15 | 48.58 | 70.63 | 69.39 | 68.57 | -- |
| Total Assets | 100.70 | 109.97 | 91.71 | 91.44 | 90.48 | 49.19 | 48.68 | 70.71 | 69.85 | 68.82 | 0.26 |
| Accounts Payable | 8.88 | 10.45 | 8.67 | 7.68 | 5.87 | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | 58.81 | 44.71 | 52.99 | 49.74 | 43.40 | 3.08 | 2.82 | 1.17 | 0.46 | 0.05 | 0.27 |
| Total Non-current Liabilities* | 6.62 | 6.85 | 6.32 | 6.06 | 5.79 | 49.15 | 48.32 | 70.63 | 69.39 | 68.57 | 0.00 |
| Total Liabilities* | 65.43 | 51.56 | 59.31 | 55.80 | 49.19 | 52.23 | 51.14 | 71.80 | 69.85 | 68.62 | 0.27 |
| Retained Earnings | (96.18) | (69.57) | (59.04) | (53.67) | (45.94) | (3.04) | (2.46) | (1.08) | -0.00 | 0.20 | (0.01) |
| Total Stockholder Equity | 35.27 | 58.41 | 32.40 | 35.64 | 41.29 | (3.04) | (2.46) | (1.08) | -0.00 | 0.20 | (0.01) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 |
|---|
| Total Revenue | 1.67 | 3.94 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cost of Revenue | 0.33 | 0.79 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | 1.34 | 3.15 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | 1.08 | 1.02 | 1.08 | 0.94 | 3.14 | 1.26 | 1.30 | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, General & Admin | 23.63 | 2.86 | 1.34 | 1.88 | 2.24 | 3.32 | 5.15 | 0.38 | 0.27 | -- | 0.42 | 0.20 | 0.15 | -- | -- |
| Total Operating Expenses | 29.95 | 8.41 | 4.71 | 4.94 | 7.47 | 6.39 | 6.67 | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Income | (28.61) | (5.25) | (4.71) | (4.94) | -- | -- | -- | (0.38) | (0.27) | (0.24) | (0.42) | (0.20) | (0.15) | -- | -- |
| Pretax Income | (26.84) | (5.27) | (4.73) | (5.11) | (7.47) | (6.39) | (6.67) | -- | -- | -- | -- | -- | -- | -- | -- |
| Tax Provision | (0.23) | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.14 | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | (26.61) | (5.53) | (5.00) | (5.37) | (7.74) | (6.66) | (14.08) | 0.25 | 0.49 | -- | 0.16 | 0.62 | 0.61 | -- | -0.00 |
| Basic EPS | (0.27) | (0.06) | (0.06) | (0.08) | (0.11) | (0.09) | (0.35) | 0.04 | 0.07 | -- | 0.02 | 0.07 | 0.07 | 0.12 | 0.00 |
| Diluted EPS | (0.27) | (0.06) | (0.06) | (0.08) | (0.11) | (0.09) | (0.35) | 0.04 | 0.07 | -- | 0.02 | 0.07 | 0.07 | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 |
|---|
| Operating Cash Flow | (3.83) | (7.35) | (0.37) | (0.19) | (0.22) | (0.11) | (0.10) | (0.17) |
| Investing Cash Flow | (0.60) | (4.40) | 0.07 | 24.74 | (0.66) | (0.66) | -- | -- |
| Financing Cash Flow | (0.23) | 15.13 | 0.26 | (24.55) | 0.89 | 0.43 | 0.35 | -- |
